San Jacinto College and McCord Development Partnership with NIBRTBy Publishing TeamJanuary 16, 2023 San Jacinto College (San Jac) and McCord Development have signed a Memorandum of Understanding with the National Institute for Bioprocessing…
EverImmune Initiates Phase I Clinical Trial for Its Oncobiotic Drug Candidate in Lung and Kidney Cancer | DNA RNA and CellsBy Publishing TeamJanuary 16, 2023 EverImmune launches a phase I clinical trial for its oncobiotic drug candidate in lung and kidney cancer Details Category: DNA…
Goodwin Biotechnology becomes GBI | Pharmaceutical contractBy Publishing TeamJanuary 2, 2023 Goodwin Biotechnology becomes GBI and expands to launch an all-new, larger capacity cGMP biologics facility. Although the name may change,…
Polyplus acquires French biotech CDMO Bio ElpidaBy Publishing TeamJanuary 2, 2023 Polyplus, a solutions provider for manufacturing advanced therapeutic drugs from research to commercial grade, has acquired Bio Elpida, a French…
